1 / 30

Palliative care

Palliative care. For cancer patients Team approach. Sympathy is not enough. What can we do ?. Better quality of life. Cancer pain management. Dr. Ahmed Helmy Abouel Soud Board member of WSPC Professor of Pain Relief, N.C.I., Cairo University, Egypt. Cancer pain. 70 % of advanced cases

reid
Télécharger la présentation

Palliative care

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Palliative care For cancer patients Team approach

  2. Sympathy is not enough

  3. What can we do ?

  4. Better quality of life

  5. Cancerpainmanagement Dr. Ahmed Helmy Abouel Soud Board member of WSPC Professor of Pain Relief, N.C.I., Cairo University, Egypt

  6. Cancerpain • 70 % of advanced cases • Any site & any type

  7. Tools • Drugs • Interventions

  8. Pharmacotherapy • WHO ladder system • By the clock • Oral or transdermal rout • Full dose

  9. WHO ladder system • Non opioid ± adjuvants • Weak opioids + I • Strong opioids + I

  10. Oral weak opioids e.g. tramundine, D.H.C. Oral strong opioids e.g. MST, oxycontin and MXL Transdermal e.g. Fentanyl patch (Durogesic) Sustainedreleaseopioids

  11. Simpler, thinner Better adhesion Fentanyl in dissolved state with no ethanol as permeation enhancer Can be divided Guarantee stable blood fentanyl level for 72 h Newer Fentanyl (Durogesic) patch

  12. Side effects

  13. Delivery of opioids to the C.N.S. Destruction of pain pathway Pain interventionsminimally invasive procedures

  14. Delivery of opioids to the C.N.S. • Frequent delivery by special device • Generalized pain, initial good response to the systemic drug with appearance of tolerance or side effects, adequate test response • Better response with lower dose and lesser side effects

  15. Pain pathway destruction • Advanced cancer • Localized severe pain • Accessible target

  16. Ideal procedure • Life long • High success rate with selective destruction • Complete or satisfactory pain relief • Percutaneous by R.F. or neurolytics • Under local anesthesia • No or minimal morbidity

  17. Commontargets • Celiac plexus • Superior hypogastric plexus • Ganglion impar • Posterior root • Spinothalamic tract • Trigeminal tract & nucleus

  18. Neurolytic procedures • Celiac plexus • Superior hypogastric plexus • Ganglion impar • Posterior root

  19. Celiac plexus destruction • Upper abdominal visceral pain • Pancreas, hepatobiliary, stomach, intestine • 85% success

  20. CeliacPlexus

  21. Superior hypogastric plexus destruction • Pelvic visceral pain • Bladder, prostate, cervix, uterus, ovary, colon& rectum • 75% success

  22. Ganglion impar • Junction of the two paravertebral sympathetic chains • Sacroccygeal junction • SMP at the perineal region • Ca rectum, anal canal, vagina& vulva • 50-60% success

  23. Posterior (sensory) root • Localized somatic • Rib metastases, ca rectum & anal canal • 70% success • Sensory loss

  24. Cordotomy Tractotomy-nucleotomy Spinothalamic tract Trigeminal tract & nucleus Percutaneous RF procedures

  25. Crossed fibers Anterolateral quadrant Pain & temperature Somatotopic organization Important relations Spinothalamic tract

  26. Cordotomy • Unilateral cancer pain below the clavicle • Lung, pleura, pelvic bones & muscles, upper & lower limb • 95% success • Loss of pinprick & temp

  27. Descending trigeminal tract & subnucleus caudalis • Posterolateral part • Joined by VII, IX and X • Somatotopic organization • Important relations • Pain & temperature

  28. Trigeminal Tractotomy-Nucleotomy • Percutaneous • under L.A. & sedation • C-T guided • R.F. • Occiput / C1 level • 75 % success

  29. Can we offer this ?

More Related